Childhood Absence Epilepsy, Juvenile Absence Epilepsy research hub

A multicenter, open-label, single-arm study to evaluate long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy

This study looks at the long-term safety of an epilepsy medicine called brivaracetam. It is for adults living with childhood or juvenile absence epilepsy, a condition causing brief daydream-like pauses. Researchers want to see how well patients tolerate the medicine and track any side effects over time.